叶酸与锌补充对男性精液质量及活产率的影响:随机临床试验
这项多中心随机临床试验纳入2370对计划接受不孕治疗的夫妇,男性每日补充5 mg叶酸和30 mg元素锌或安慰剂6个月。结果显示,补充组与安慰剂组的活产率无显著差异(34% vs 35%;风险差-0.9% [95%CI -4.7%至2.8%]),多数精液质量参数无显著改善,但DNA碎片率显著增加(平均差异2.4% [95%CI 0.5%至4.4%])。结论不支持男性伴侣在不孕治疗中常规补充叶酸和锌。
要点
- 男性每日补充5 mg叶酸和30 mg锌6个月未提高夫妇活产率。
- 多数精液质量参数无显著改善,但DNA碎片率显著增加。
- 补充组胃肠道症状(腹部不适、恶心、呕吐)更常见。
核心结论
- 在寻求不孕治疗的一般人群中,男性伴侣补充叶酸和锌与安慰剂相比未显著改善精液质量或夫妇活产率。
- 这些发现不支持在不孕治疗中让男性伴侣使用叶酸和锌补充剂。
研究设计与样本
- 多中心随机临床试验(叶酸和锌补充试验),在美国4个生殖内分泌与不孕治疗研究中心开展。
- 男性按研究中心和计划不孕治疗方式(体外受精、研究中心其他治疗、外院其他治疗)进行区组随机,每日接受5 mg叶酸和30 mg元素锌(n=1185)或安慰剂(n=1185),持续6个月。
主要发现
- 活产率在叶酸和锌组与安慰剂组间无显著差异:404例(34%)vs 416例(35%),风险差-0.9%(95%CI -4.7%至2.8%)。
- 随机化后6个月,大多数精液质量参数(精子浓度、活力、形态、体积和总活动精子计数)在两组间无显著差异。
- 叶酸和锌补充组DNA碎片率显著增加:平均百分比29.7% vs 27.2%,平均差异2.4%(95%CI 0.5%至4.4%)。
- 胃肠道症状在叶酸和锌组更常见:腹部不适或疼痛66例(6%)vs 40例(3%),恶心50例(4%)vs 24例(2%),呕吐32例(3%)vs 17例(1%)。
临床怎么用
- 临床不应基于改善精液质量或提高活产率的目的,常规推荐男性不孕治疗伴侣补充叶酸和锌。
- 对于正在考虑或已使用叶酸和锌补充剂的男性,应告知其缺乏获益证据且可能增加DNA碎片率和胃肠道症状。
局限性
- 随机化男性2370人中,1773人(75%)完成最终6个月研究访视,1629人(69%)有精液可供分析。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Dietary supplements marketed for male fertility commonly contain folic acid and zinc based on limited prior evidence for improving semen quality. However, no large-scale trial has examined the efficacy of this therapy for improving semen quality or live birth. OBJECTIVE: To determine the effect of daily folic acid and zinc supplementation on semen quality and live birth. DESIGN, SETTING, AND PARTICIPANTS: The Folic Acid and Zinc Supplementation Trial was a multicenter randomized clinical trial. Couples (n = 2370; men aged ≥18 years and women aged 18-45 years) planning infertility treatment were enrolled at 4 US reproductive endocrinology and infertility care study centers between June 2013 and December 2017. The last 6-month study visit for semen collection occurred during August 2018, with chart abstraction of live birth and pregnancy information completed during April 2019. INTERVENTIONS: Men were block randomized by study center and planned infertility treatment (in vitro fertilization, other treatment at a study site, and other treatment at an outside clinic) to receive either 5 mg of folic acid and 30 mg of elemental zinc (n = 1185) or placebo (n = 1185) daily for 6 months. MAIN OUTCOMES AND MEASURES: The co-primary outcomes were live birth (resulting from pregnancies occurring within 9 months of randomization) and semen quality parameters (sperm concentration, motility, morphology, volume, DNA fragmentation, and total motile sperm count) at 6 months after randomization. RESULTS: Among 2370 men who were randomized (mean age, 33 years), 1773 (75%) attended the final 6-month study visit. Live birth outcomes were available for all couples, and 1629 men (69%) had semen available for analysis at 6 months after randomization. Live birth was not significantly different between treatment groups (404 [34%] in the folic acid and zinc group and 416 [35%] in the placebo group; risk difference, -0.9% [95% CI, -4.7% to 2.8%]). Most of the semen quality parameters (sperm concentration, motility, morphology, volume, and total motile sperm count) were not significantly different between treatment groups at 6 months after randomization. A statistically significant increase in DNA fragmentation was observed with folic acid and zinc supplementation (mean of 29.7% for percentage of DNA fragmentation in the folic acid and zinc group and 27.2% in the placebo group; mean difference, 2.4% [95% CI, 0.5% to 4.4%]). Gastrointestinal symptoms were more common with folic acid and zinc supplementation compared with placebo (abdominal discomfort or pain: 66 [6%] vs 40 [3%], respectively; nausea: 50 [4%] vs 24 [2%]; and vomiting: 32 [3%] vs 17 [1%]). CONCLUSIONS AND RELEVANCE: Among a general population of couples seeking infertility treatment, the use of folic acid and zinc supplementation by male partners, compared with placebo, did not significantly improve semen quality or couples' live birth rates. These findings do not support the use of folic acid and zinc supplementation by male partners in the treatment of infertility. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01857310.
引用
- Schisterman EF, Sjaarda LA, Clemons T, et al. Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial. JAMA. 2020. PMID: 31910279. doi:10.1001/jama.2019.18714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。